We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLI icon
301
Houlihan Lokey
HLI
$9.72B
$1.63M 0.12%
10,088
+7,566
+300% +$1.3M
AKAM icon
302
Akamai
AKAM
$15.6B
$1.62M 0.11%
20,100
RKT icon
303
Rocket Companies
RKT
$38.8B
$1.6M 0.11%
132,682
-188,909
-59% -$2.44M
RUSHA icon
304
Rush Enterprises Class A
RUSHA
$6.34B
$1.59M 0.11%
29,842
+11,172
+60% +$641K
AGRO icon
305
Adecoagro
AGRO
$1.4B
$1.58M 0.11%
141,592
+104,598
+283% +$1.07M
MEOH icon
306
Methanex
MEOH
$4.23B
$1.58M 0.11%
44,887
+6,740
+18% +$303K
MLNK
307
DELISTED
MeridianLink
MLNK
$1.56M 0.11%
84,377
+21,759
+35% +$420K
APPN icon
308
Appian
APPN
$2.11B
$1.56M 0.11%
54,111
+10,230
+23% +$335K
RACE icon
309
Ferrari
RACE
$67.8B
$1.56M 0.11%
3,640
+930
+34% +$418K
REPL icon
310
Replimune Group
REPL
$455M
$1.55M 0.11%
158,760
-34
-0% -$421
FSM icon
311
Fortuna Silver Mines
FSM
$2.54B
$1.54M 0.11%
+253,200
New +$1.26M
LRCX icon
312
Lam Research
LRCX
$316B
$1.54M 0.11%
21,234
-31,486
-60% -$2.48M
MANU icon
313
Manchester United
MANU
$4.03B
$1.54M 0.11%
117,601
+94,155
+402% +$1.42M
G icon
314
Genpact
G
$6.22B
$1.53M 0.11%
30,365
+9,186
+43% +$455K
OS
315
DELISTED
OneStream Inc
OS
$1.52M 0.11%
71,438
+14
+0% +$359
BNS icon
316
Scotiabank
BNS
$105B
$1.52M 0.11%
+32,100
New +$1.61M
SITM icon
317
SiTime
SITM
$13.8B
$1.52M 0.11%
9,943
+1
+0% +$192
NVT icon
318
nVent Electric
NVT
$21.6B
$1.5M 0.11%
28,690
+15,821
+123% +$1M
NYT icon
319
New York Times
NYT
$12.6B
$1.5M 0.11%
30,172
+30
+0.1% +$1.51K
ADMA icon
320
ADMA Biologics
ADMA
$2.02B
$1.48M 0.1%
+74,414
New +$1.29M
BR icon
321
Broadridge
BR
$18.4B
$1.46M 0.1%
6,037
-3
-0% -$706
ROAD icon
322
Construction Partners
ROAD
$5.88B
$1.45M 0.1%
+20,205
New +$1.59M
WAY
323
Waystar Holding Corp
WAY
$4.7B
$1.45M 0.1%
+38,701
New +$1.53M
PRIM icon
324
Primoris Services
PRIM
$4.06B
$1.44M 0.1%
25,046
-13,143
-34% -$950K
LAD icon
325
Lithia Motors
LAD
$9.75B
$1.41M 0.1%
+4,814
New +$1.64M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.